Hepion Pharmaceuticals Inc logo

Hepion Pharmaceuticals Inc

$ 0.49 -0.0191 (-3.74%) 04:00 PM EST
P/E:
At Loss
P/B:
0.58
Market Cap:
$ 37.44M
Enterprise V:
$ -30.94M
Volume:
120.47K
Avg Vol (2M):
130.75K
Also Trade In:
Volume:
120.47K
Market Cap $:
37.44M
PE Ratio:
At Loss
Avg Vol (2-Month):
130.75K
Enterprise Value $:
-30.94M
PB Ratio:
0.58
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on the development of drug therapy for the treatment of chronic liver diseases. This therapeutic approach targets fibrosis and hepatocellular carcinoma associated with non-alcoholic steatohepatitis, viral hepatitis, and other liver diseases. Its cyclophilin inhibitor, Rencofilstat, is being developed to offer benefits to address these multiple complex pathologies. Rencofilstat is a pan cyclophilin inhibitor that targets multiple pathologic pathways involved in the progression of liver disease.
Name Current Vs Industry Vs History
Cash-To-Debt 405.13
Equity-to-Asset 0.81
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score 0
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 42.5
9-Day RSI 35.75
14-Day RSI 35.6
6-1 Month Momentum % -49.08
12-1 Month Momentum % -60.7

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 5.95
Quick Ratio 5.95
Cash Ratio 5.36

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -584.9
Name Current Vs Industry Vs History
ROE % -49.79
ROA % -44.56
ROIC % -450.88
ROC (Joel Greenblatt) % -3379.37
ROCE % -48.52

Financials (Next Earnings Date:2022-11-15 Est.)

HEPA's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:HEPA

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0
EPS (TTM) ($) -0.6
Beta 1.59
Volatility % 61.24
14-Day RSI 35.6
14-Day ATR ($) 0.042635
20-Day SMA ($) 0.547935
12-1 Month Momentum % -60.7
52-Week Range ($) 0.47 - 1.6
Shares Outstanding (Mil) 76.23

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Hepion Pharmaceuticals Inc Filings

Document Form Filing Date
No Filing Data

Hepion Pharmaceuticals Inc Analysis

Share your research

Headlines

See More
No news.